Increase in plasma renin level and aldosterone excretion in response to bethanidine sulfate (Esbatal) in a patient with renovascular hypertension.
D000450:Aldosterone / Q000652:urine*; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004231:Diuresis; D005919:Glomerular Filtration Rate; D006146:Guanidines / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000652:urine; D006977:Hypertension, Renal / Q000188:drug therapy / Q000503:physiopathology*; D007668:Kidney / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood / Q000652:urine; D011859:Radiography; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000097:blood / Q000652:urine; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000494:pharmacology* / Q000627:therapeutic use
D000959:Antihypertensive Agents; D006146:Guanidines; D013565:Sympatholytics; D000450:Aldosterone; D012964:Sodium; D012083:Renin; D011188:Potassium; D006854:Hydrocortisone